Skip to main content
TipRanks
Go Ultimate75% OFF

Addex Therapeutics (ADXN) Ownership - Who Owns Addex Therapeutics?

86 Followers

Addex Therapeutics (ADXN) Ownership Overview

  • 67.23% Insiders
  • 0.05% Other Institutional Investors
  • 32.71% Public Companies and Individual Investors

The ownership structure of Addex Therapeutics (ADXN) stock is a mix of institutional, retail, and individual investors. Approximately 0.05% of the company’s stock is owned by Institutional Investors, 67.23% is owned by Insiders, and 32.71% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

ADXN top shareholders
Holder# of SharesType% HoldingValue
Vincent Michael Lawton2,507,987Insider96.57%10,182,427
Raymond George Hill1,365,532Insider52.58%5,544,060
Roger Mills785,976Insider30.26%3,191,063
Mikhail Kalinichev306,765Insider11.81%1,245,466
Jason Raleigh Nunn219,561Insider8.45%891,418
Isaac Manke219,561Insider8.45%891,418

FAQ

Who Owns Addex Therapeutics (ADXN)?
According to the latest TipRanks data, approximately 0.05% of the company's stock is held by institutional investors, 67.23% is held by insiders, and 32.71% is held by public companies and individual investors.
What percentage of Addex Therapeutics (ADXN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.05% of Addex Therapeutics (ADXN) stock is held by institutional investors.
What percentage of Addex Therapeutics (ADXN) stock is held by retail investors?
According to the latest TipRanks data, approximately 32.71% of Addex Therapeutics (ADXN) stock is held by public companies and individual investors.
Who owns the most shares of Addex Therapeutics (ADXN)?
Vincent Michael Lawton owns the most shares of Addex Therapeutics (ADXN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.